Aragen announces partnership with Skyhawk Therapeutics, aimed at developing novel small molecule therapeutics that correct RNA expression
Aragen Life Sciences (formerly, GVK BIO), a leading Contract Research and Development Organization (CRDO), headquartered out of Hyderabad, India, announced that it has been selected by Skyhawk Therapeutics, a leader in the development of small molecule therapeutics that correct RNA expression, as its partner in India.
ANI | Hyderabad (Telangana) | Updated: 15-07-2021 13:02 IST | Created: 15-07-2021 13:02 IST
Aragen Life Sciences. Image Credit: ANI
Country:
SHARE
Hyderabad (Telangana) [India], July 15 (ANI/BusinessWire India): Aragen Life Sciences (formerly, GVK BIO), a leading Contract Research and Development Organization (CRDO), headquartered out of Hyderabad, India, announced that it has been selected by Skyhawk Therapeutics, a leader in the development of small molecule therapeutics that correct RNA expression, as its partner in India.
Aragen Life Sciences Pvt Ltd: Aragen Announces Partnership with Skyhawk Therapeutics, Aimed at Developing Novel Small Molecule Therapeutics that Correct RNA Expression
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Aragen Life Sciences partners Skyhawk Therapeutics to develop novel small molecule therapeutics
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.